Title : Decreased expression of microRNA-17 and microRNA-20b promotes breast cancer resistance to taxol therapy by upregulation of NCOA3.

Pub. Date : 2016 Nov 10

PMID : 27831559






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Decreased expression of microRNA-17 and microRNA-20b promotes breast cancer resistance to taxol therapy by upregulation of NCOA3. Paclitaxel microRNA 17 Homo sapiens
2 By real-time PCR analysis, we found that miR-17 and miR-20b were significantly reduced in taxol-resistant breast cancer tissues and cells. Paclitaxel microRNA 17 Homo sapiens
3 In addition, we provided some experimental evidences that miR-17 and miR-20b attenuated breast cancer resistance to taxol in vitro and in vivo models. Paclitaxel microRNA 17 Homo sapiens
4 Together, our results indicated that loss of miR-17 and miR-20b enhanced breast cancer resistance to taxol by upregulating NCOA3 levels. Paclitaxel microRNA 17 Homo sapiens
5 Our study suggested miR-17, miR-20b and NCOA3 may serve as some predictive biomarkers and potential therapeutic targets in taxol-resistant breast cancer treatment. Paclitaxel microRNA 17 Homo sapiens